| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A chlamydial type III-secreted effector protein (Tarp) is predominantly recognized by antibodies from humans infected with Chlamydia trachomatis and induces protective immunity against upper genital tract pathologies in mice
|
Wang, Jie
|
|
2009
|
27 |
Supplement 1 |
p. 2967-2980
14 p.
|
artikel
|
| 2 |
Acute cerebellar ataxia in the Netherlands: A study on the association with vaccinations and varicella zoster infection
|
van der Maas, N.A.T.
|
|
2009
|
27 |
Supplement 1 |
p. 1970-1973
4 p.
|
artikel
|
| 3 |
Addition of interferon-alpha to a standard maturation cocktail induces CD38 up-regulation and increases dendritic cell function
|
Trepiakas, Redas
|
|
2009
|
27 |
Supplement 1 |
p. 2213-2219
7 p.
|
artikel
|
| 4 |
Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990–2007
|
Niu, Manette T.
|
|
2009
|
27 |
Supplement 1 |
p. 290-297
8 p.
|
artikel
|
| 5 |
AIDSVAX immunization induces HIV-specific CD8+ T-cell responses in high-risk, HIV-negative volunteers who subsequently acquire HIV infection
|
Jones, Norman G.
|
|
2009
|
27 |
Supplement 1 |
p. 1136-1140
5 p.
|
artikel
|
| 6 |
A Japanese encephalitis virus vaccine candidate strain is attenuated by decreasing its interferon antagonistic ability
|
Liang, Jian-Jong
|
|
2009
|
27 |
Supplement 1 |
p. 2746-2754
9 p.
|
artikel
|
| 7 |
Amended recombinant cells (ARCs™) expressing bovine IFN-γ: An economical and highly effective adjuvant system
|
Gaertner, Frank H.
|
|
2009
|
27 |
Supplement 1 |
p. 1377-1385
9 p.
|
artikel
|
| 8 |
Ampligen: A potential toll-like 3 receptor adjuvant for immunotherapy of cancer
|
Jasani, B.
|
|
2009
|
27 |
Supplement 1 |
p. 3401-3404
4 p.
|
artikel
|
| 9 |
Analysis of biomarkers after intramuscular injection of Vaxfectin®-formulated hCMV gB plasmid DNA
|
Vilalta, Adrián
|
|
2009
|
27 |
Supplement 1 |
p. 7409-7417
9 p.
|
artikel
|
| 10 |
An E7-based therapeutic vaccine protects mice against HPV16 associated cancer
|
Venuti, Aldo
|
|
2009
|
27 |
Supplement 1 |
p. 3395-3397
3 p.
|
artikel
|
| 11 |
Antibodies induced by vaccination with purified chick embryo cell culture vaccine (PCECV) cross-neutralize non-classical bat lyssavirus strains
|
Malerczyk, Claudius
|
|
2009
|
27 |
Supplement 1 |
p. 5320-5325
6 p.
|
artikel
|
| 12 |
Antibody kinetics among 8–10 years old respondents to hepatitis B vaccination in a low endemic country and the effect of a booster dose given 5 or 10 years later
|
Gilca, Vladimir
|
|
2009
|
27 |
Supplement 1 |
p. 6048-6053
6 p.
|
artikel
|
| 13 |
Antibody quantity versus quality after influenza vaccination
|
Feng, JingQi
|
|
2009
|
27 |
Supplement 1 |
p. 6358-6362
5 p.
|
artikel
|
| 14 |
Antibody response following administration of two paediatric tick-borne encephalitis vaccines using two different vaccination schedules
|
Wittermann, Christoph
|
|
2009
|
27 |
Supplement 1 |
p. 1661-1666
6 p.
|
artikel
|
| 15 |
Antibody responses against NY-ESO-1 and HER2 antigens in patients vaccinated with combinations of cholesteryl pullulan (CHP)-NY-ESO-1 and CHP-HER2 with OK-432
|
Aoki, Masatoshi
|
|
2009
|
27 |
Supplement 1 |
p. 6854-6861
8 p.
|
artikel
|
| 16 |
Antibody responses to a panel of Plasmodium falciparum malaria blood-stage antigens in relation to clinical disease outcome in Sudan
|
Iriemenam, Nnaemeka C.
|
|
2009
|
27 |
Supplement 1 |
p. 62-71
10 p.
|
artikel
|
| 17 |
Antibody response to an eight-site intradermal rabies vaccination in patients infected with Human Immunodeficiency Virus
|
Sirikwin, Siriwan
|
|
2009
|
27 |
Supplement 1 |
p. 4350-4354
5 p.
|
artikel
|
| 18 |
Anti-β-glucan antibodies in healthy human subjects
|
Chiani, P.
|
|
2009
|
27 |
Supplement 1 |
p. 513-519
7 p.
|
artikel
|
| 19 |
A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel® with CPG 7909, using two different formulations and dosing intervals
|
Ellis, Ruth D.
|
|
2009
|
27 |
Supplement 1 |
p. 4104-4109
6 p.
|
artikel
|
| 20 |
A prime/boost DNA/Modified vaccinia virus Ankara vaccine expressing recombinant Leishmania DNA encoding TRYP is safe and immunogenic in outbred dogs, the reservoir of zoonotic visceral leishmaniasis
|
Carson, Connor
|
|
2009
|
27 |
Supplement 1 |
p. 1080-1086
7 p.
|
artikel
|
| 21 |
A prime–boost immunisation regimen using recombinant BCG and Pr55gag virus-like particle vaccines based on HIV type 1 subtype C successfully elicits Gag-specific responses in baboons
|
Chege, Gerald K.
|
|
2009
|
27 |
Supplement 1 |
p. 4857-4866
10 p.
|
artikel
|
| 22 |
A prime–boost vaccination of mice with heterologous H5N1 strains
|
Ikeno, Daisuke
|
|
2009
|
27 |
Supplement 1 |
p. 3121-3125
5 p.
|
artikel
|
| 23 |
A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1/Alhydrogel® +CPG 7909 vaccine for Plasmodium falciparum malaria in semi-immune Malian adults
|
Sagara, Issaka
|
|
2009
|
27 |
Supplement 1 |
p. 7292-7298
7 p.
|
artikel
|
| 24 |
A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in Mali
|
Sagara, Issaka
|
|
2009
|
27 |
Supplement 1 |
p. 3090-3098
9 p.
|
artikel
|
| 25 |
A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy
|
Gandhi, Rajesh T.
|
|
2009
|
27 |
Supplement 1 |
p. 6088-6094
7 p.
|
artikel
|
| 26 |
A recombinant vesicular stomatitis virus replicon vaccine protects chickens from highly pathogenic avian influenza virus (H7N1)
|
Kalhoro, Nazeer H.
|
|
2009
|
27 |
Supplement 1 |
p. 1174-1183
10 p.
|
artikel
|
| 27 |
Ascaris suum infection negatively affects the response to a Mycoplasma hyopneumoniae vaccination and subsequent challenge infection in pigs
|
Steenhard, Nina R.
|
|
2009
|
27 |
Supplement 1 |
p. 5161-5169
9 p.
|
artikel
|
| 28 |
A single component two-valent LcrV-F1 vaccine protects non-human primates against pneumonic plague
|
Chichester, Jessica A.
|
|
2009
|
27 |
Supplement 1 |
p. 3471-3474
4 p.
|
artikel
|
| 29 |
Assessment of immunogenic potential of Vero adapted formalin inactivated vaccine derived from novel ECSA genotype of Chikungunya virus
|
Tiwari, Mugdha
|
|
2009
|
27 |
Supplement 1 |
p. 2513-2522
10 p.
|
artikel
|
| 30 |
Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease
|
Frasch, Carl E.
|
|
2009
|
27 |
Supplement 1 |
p. B112-B116
nvt p.
|
artikel
|
| 31 |
BAFF enhances B-cell-mediated immune response and vaccine-protection against a very virulent IBDV in chickens
|
Chen, Long
|
|
2009
|
27 |
Supplement 1 |
p. 1393-1399
7 p.
|
artikel
|
| 32 |
Basal and stimulus-induced cytokine expression is selectively impaired in peripheral blood mononuclear cells of newborn foals
|
Liu, Tong
|
|
2009
|
27 |
Supplement 1 |
p. 674-683
10 p.
|
artikel
|
| 33 |
Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: Benefits of mortality reduction versus risk of fatal intussusception
|
Patel, Manish M.
|
|
2009
|
27 |
Supplement 1 |
p. 2916-2922
7 p.
|
artikel
|
| 34 |
Brucellosis: The case for live, attenuated vaccines
|
Ficht, Thomas A.
|
|
2009
|
27 |
Supplement 1 |
p. D40-D43
nvt p.
|
artikel
|
| 35 |
Burden of rotavirus disease and cost-effectiveness of universal vaccination in the Province of Genoa (Northern Italy)
|
Panatto, D.
|
|
2009
|
27 |
Supplement 1 |
p. 3450-3453
4 p.
|
artikel
|
| 36 |
Cell-mediated immunity elicited by the blood stage malaria vaccine apical membrane antigen 1 in Malian adults: Results of a Phase I randomized trial
|
Lyke, Kirsten E.
|
|
2009
|
27 |
Supplement 1 |
p. 2171-2176
6 p.
|
artikel
|
| 37 |
Challenge studies in Rhesus monkeys immunized with candidate hepatitis E vaccines: DNA, DNA-prime-protein-boost and DNA-protein encapsulated in liposomes
|
Arankalle, Vidya A.
|
|
2009
|
27 |
Supplement 1 |
p. 1032-1039
8 p.
|
artikel
|
| 38 |
Characterization of possible correlates of protective response against Brucella ovis infection in rams immunized with the B. melitensis Rev 1 vaccine
|
Galindo, Ruth C.
|
|
2009
|
27 |
Supplement 1 |
p. 3039-3044
6 p.
|
artikel
|
| 39 |
Characterization of recombinant influenza A virus as a vector for HIV-1 p17Gag
|
de Goede, Anna L.
|
|
2009
|
27 |
Supplement 1 |
p. 5735-5739
5 p.
|
artikel
|
| 40 |
Codon stabilization analysis of the “248” temperature sensitive mutation for increased phenotypic stability of respiratory syncytial virus vaccine candidates
|
Luongo, Cindy
|
|
2009
|
27 |
Supplement 1 |
p. 5667-5676
10 p.
|
artikel
|
| 41 |
Combining DNA technologies and different modes of immunization for induction of humoral and cellular anti-HIV-1 immune responses
|
Bråve, Andreas
|
|
2009
|
27 |
Supplement 1 |
p. 184-186
3 p.
|
artikel
|
| 42 |
Comparison of DNA vaccines producing HIV-1 Gag and LAMP/Gag chimera in rhesus macaques reveals antigen-specific T-cell responses with distinct phenotypes
|
Valentin, Antonio
|
|
2009
|
27 |
Supplement 1 |
p. 4840-4849
10 p.
|
artikel
|
| 43 |
Comparison of efficacy of commercial one dose and two dose PCV2 vaccines using a mixed PRRSV–PCV2–SIV clinical infection model 2–3-months post vaccination
|
Opriessnig, T.
|
|
2009
|
27 |
Supplement 1 |
p. 1002-1007
6 p.
|
artikel
|
| 44 |
Comparison of humoral and cellular immune responses to a pentavalent modified live virus vaccine in three age groups of calves with maternal antibodies, before and after BVDV type 2 challenge
|
Platt, Ratree
|
|
2009
|
27 |
Supplement 1 |
p. 4508-4519
12 p.
|
artikel
|
| 45 |
Comparison of immunogenicity of five MSP1-based malaria vaccine candidate antigens in rabbits
|
Reed, Zarifah Hussain
|
|
2009
|
27 |
Supplement 1 |
p. 1651-1660
10 p.
|
artikel
|
| 46 |
Construction and cellular immune response induction of HA-based alphavirus replicon vaccines against human-avian influenza (H5N1)
|
Yang, Shi-gui
|
|
2009
|
27 |
Supplement 1 |
p. 7451-7458
8 p.
|
artikel
|
| 47 |
Correlation between humoral and cellular immune responses and the expression of the hepatitis A receptor HAVcr-1 on T cells after hepatitis A re-vaccination in high and low-responder vaccinees
|
Garner-Spitzer, Erika
|
|
2009
|
27 |
Supplement 1 |
p. 197-204
8 p.
|
artikel
|
| 48 |
Cost–benefit comparisons of investments in improved water supply and cholera vaccination programs
|
Jeuland, Marc
|
|
2009
|
27 |
Supplement 1 |
p. 3109-3120
12 p.
|
artikel
|
| 49 |
Cross-reactive HIV-1-neutralizing activity of serum IgG from a rabbit immunized with gp41 fused to IgG1 Fc: Possible role of the prolonged half-life of the immunogen
|
Zhang, Mei-Yun
|
|
2009
|
27 |
Supplement 1 |
p. 857-863
7 p.
|
artikel
|
| 50 |
Cynomolgus macaques immunized with two HIV-1 Tat stabilized proteins raise strong and long-lasting immune responses with a pattern of Th1/Th2 response differing from that in mice
|
Turbant, Sabrina
|
|
2009
|
27 |
Supplement 1 |
p. 5349-5356
8 p.
|
artikel
|
| 51 |
Cytokine and antibody profiles in 1-year-old children vaccinated with either acellular or whole-cell pertussis vaccine during infancy
|
Dirix, V.
|
|
2009
|
27 |
Supplement 1 |
p. 6042-6047
6 p.
|
artikel
|
| 52 |
Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response
|
Kagina, Benjamin M.N.
|
|
2009
|
27 |
Supplement 1 |
p. 5488-5495
8 p.
|
artikel
|
| 53 |
Dendritic cells loaded with HIV-1 p24 proteins adsorbed on surfactant-free anionic PLA nanoparticles induce enhanced cellular immune responses against HIV-1 after vaccination
|
Aline, Fleur
|
|
2009
|
27 |
Supplement 1 |
p. 5284-5291
8 p.
|
artikel
|
| 54 |
Design and evaluation of multi-gene, multi-clade HIV-1 MVA vaccines
|
Earl, Patricia L.
|
|
2009
|
27 |
Supplement 1 |
p. 5885-5895
11 p.
|
artikel
|
| 55 |
Design and preclinical development of a recombinant protein and DNA plasmid mixed format vaccine to deliver HIV-derived T-lymphocyte epitopes
|
Walker, Leslie E.
|
|
2009
|
27 |
Supplement 1 |
p. 7087-7095
9 p.
|
artikel
|
| 56 |
Detection by ELISA of antibodies to Japanese encephalitis virus nonstructural 1 protein induced in subclinically infected humans
|
Konishi, Eiji
|
|
2009
|
27 |
Supplement 1 |
p. 7053-7058
6 p.
|
artikel
|
| 57 |
Development and use of SIV-based Integrase defective lentiviral vector for immunization
|
Michelini, Zuleika
|
|
2009
|
27 |
Supplement 1 |
p. 4622-4629
8 p.
|
artikel
|
| 58 |
Development of duck hepatitis A virus type 3 vaccine and its use to protect ducklings against infections
|
Kim, Min-Chul
|
|
2009
|
27 |
Supplement 1 |
p. 6688-6694
7 p.
|
artikel
|
| 59 |
Development of effective vaccines for old mice in a tumor model
|
Posnett, David N.
|
|
2009
|
27 |
Supplement 1 |
p. 1093-1100
8 p.
|
artikel
|
| 60 |
Development of measles vaccines in Japan
|
Ueda, Shigeharu
|
|
2009
|
27 |
Supplement 1 |
p. 3230-3231
2 p.
|
artikel
|
| 61 |
Different effects of probiotic species/strains on infections in preschool children: A double-blind, randomized, controlled study
|
Lin, Jun-Song
|
|
2009
|
27 |
Supplement 1 |
p. 1073-1079
7 p.
|
artikel
|
| 62 |
Editorial Board
|
|
|
2009
|
27 |
Supplement 1 |
p. CO2-
1 p.
|
artikel
|
| 63 |
Editorial Board
|
|
|
2009
|
27 |
Supplement 1 |
p. CO2-
1 p.
|
artikel
|
| 64 |
Editorial Board
|
|
|
2009
|
27 |
Supplement 1 |
p. CO2-
1 p.
|
artikel
|
| 65 |
Editorial Board
|
|
|
2009
|
27 |
Supplement 1 |
p. CO2-
1 p.
|
artikel
|
| 66 |
Effect of the strength of adsorption of hepatitis B surface antigen to aluminum hydroxide adjuvant on the immune response
|
Hansen, Bethany
|
|
2009
|
27 |
Supplement 1 |
p. 888-892
5 p.
|
artikel
|
| 67 |
Effects of hydrostatic pressure on the stability and thermostability of poliovirus: A new method for vaccine preservation
|
Ferreira, Evanilce
|
|
2009
|
27 |
Supplement 1 |
p. 5332-5337
6 p.
|
artikel
|
| 68 |
Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity
|
Martelli, Paolo
|
|
2009
|
27 |
Supplement 1 |
p. 3788-3799
12 p.
|
artikel
|
| 69 |
Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials
|
Rhorer, Janelle
|
|
2009
|
27 |
Supplement 1 |
p. 1101-1110
10 p.
|
artikel
|
| 70 |
Efficient and robust method for comparing the immunogenicity of candidate vaccines in randomized clinical trials
|
Gilbert, Peter B.
|
|
2009
|
27 |
Supplement 1 |
p. 396-401
6 p.
|
artikel
|
| 71 |
Enhanced humoral and Type 1 cellular immune responses with Fluzone® adjuvanted with a synthetic TLR4 agonist formulated in an emulsion
|
Baldwin, Susan L.
|
|
2009
|
27 |
Supplement 1 |
p. 5956-5963
8 p.
|
artikel
|
| 72 |
Enhancing DNA vaccination by sequential injection of lymph nodes with plasmid vectors and peptides
|
Smith, Kent A.
|
|
2009
|
27 |
Supplement 1 |
p. 2603-2615
13 p.
|
artikel
|
| 73 |
Enhancing therapeutic HPV DNA vaccine potency through depletion of CD4+CD25+ T regulatory cells
|
Chuang, Chi-Mu
|
|
2009
|
27 |
Supplement 1 |
p. 684-689
6 p.
|
artikel
|
| 74 |
Epidemiological serosurvey of Hepatitis B in China—Declining HBV prevalence due to Hepatitis B vaccination
|
Liang, Xiaofeng
|
|
2009
|
27 |
Supplement 1 |
p. 6550-6557
8 p.
|
artikel
|
| 75 |
Estimating vaccination coverage: Validity of household-retained vaccination cards and parental recall
|
Luman, Elizabeth T.
|
|
2009
|
27 |
Supplement 1 |
p. 2534-2539
6 p.
|
artikel
|
| 76 |
Evaluating the cost-effectiveness of rabies post-exposure prophylaxis: A case study in Tanzania
|
Shim, Eunha
|
|
2009
|
27 |
Supplement 1 |
p. 7167-7172
6 p.
|
artikel
|
| 77 |
Evaluation of a prime-boost vaccine schedule with distinct adenovirus vectors against malaria in rhesus monkeys
|
Rodríguez, Ariane
|
|
2009
|
27 |
Supplement 1 |
p. 6226-6233
8 p.
|
artikel
|
| 78 |
Evaluation of Japanese encephalitis virus DNA vaccine candidates in rhesus monkeys [Macaca mulatta]
|
Bharati, Kaushik
|
|
2009
|
27 |
Supplement 1 |
p. 10-16
7 p.
|
artikel
|
| 79 |
Evidence of effectiveness from a large county-wide school-based influenza immunization campaign
|
Grijalva, Carlos G.
|
|
2009
|
27 |
Supplement 1 |
p. 2633-2636
4 p.
|
artikel
|
| 80 |
Excess drug prescriptions during influenza and RSV seasons in the Netherlands: Potential implications for extended influenza vaccination
|
Assink, M.D.M.
|
|
2009
|
27 |
Supplement 1 |
p. 1119-1126
8 p.
|
artikel
|
| 81 |
Factors conditioning effectiveness of a reminder/recall system to improve influenza vaccination in asthmatic children
|
Esposito, Susanna
|
|
2009
|
27 |
Supplement 1 |
p. 633-635
3 p.
|
artikel
|
| 82 |
Field efficacy trial of a novel HVT-IBD vector vaccine for 1-day-old broilers
|
Le Gros, F.X.
|
|
2009
|
27 |
Supplement 1 |
p. 592-596
5 p.
|
artikel
|
| 83 |
Foot and mouth disease virus vaccines
|
Rodriguez, Luis L.
|
|
2009
|
27 |
Supplement 1 |
p. D90-D94
nvt p.
|
artikel
|
| 84 |
Functional and biological determinants affecting the duration of action and efficacy of anti-(+)-methamphetamine monoclonal antibodies in rats
|
Laurenzana, Elizabeth M.
|
|
2009
|
27 |
Supplement 1 |
p. 7011-7020
10 p.
|
artikel
|
| 85 |
Functional properties and epitope characteristics of T-cells recognizing natural HIV-1 variants
|
Malhotra, U.
|
|
2009
|
27 |
Supplement 1 |
p. 6678-6687
10 p.
|
artikel
|
| 86 |
Genetic engineering of a modified herpes simplex virus 1 vaccine vector
|
Liu, XueQiao
|
|
2009
|
27 |
Supplement 1 |
p. 2760-2767
8 p.
|
artikel
|
| 87 |
Ginseng stem–leaf saponins (GSLS) and mineral oil act synergistically to enhance the immune responses to vaccination against foot-and-mouth disease in mice
|
Song, Xiaoming
|
|
2009
|
27 |
Supplement 1 |
p. 51-55
5 p.
|
artikel
|
| 88 |
Global epidemiology of meningococcal disease
|
Harrison, Lee H.
|
|
2009
|
27 |
Supplement 1 |
p. B51-B63
nvt p.
|
artikel
|
| 89 |
Harnessing the unique local immunostimulatory properties of modified vaccinia Ankara (MVA) virus to generate superior tumor-specific immune responses and antitumor activity in a diversified prime and boost vaccine regimen
|
Hodge, James W.
|
|
2009
|
27 |
Supplement 1 |
p. 4475-4482
8 p.
|
artikel
|
| 90 |
Health-care provision factors associated with child immunization coverage in a city centre and a rural area in Kabul, Afghanistan
|
Hemat, Shafiqullah
|
|
2009
|
27 |
Supplement 1 |
p. 2823-2829
7 p.
|
artikel
|
| 91 |
Heterologous prime/boost immunizations of rhesus monkeys using chimpanzee adenovirus vectors
|
Santra, Sampa
|
|
2009
|
27 |
Supplement 1 |
p. 5837-5845
9 p.
|
artikel
|
| 92 |
HIV inactivation by cross-linking of photo-labeled anti-retroviral compounds with HIV reverse transcriptase
|
Colby-Germinario, Susan
|
|
2009
|
27 |
Supplement 1 |
p. 6137-6142
6 p.
|
artikel
|
| 93 |
HIV pseudovirion vaccine exposing Env “fusion intermediates”—Response to immunisation in human CD4/CCR5-transgenic rats
|
Bosch, Valerie
|
|
2009
|
27 |
Supplement 1 |
p. 2202-2212
11 p.
|
artikel
|
| 94 |
HIV-1 Tat-specific IgG antibodies in high-responders target a B-cell epitope in the cysteine-rich domain and block extracellular Tat efficiently
|
Kashi, Venkatesh Prasanna
|
|
2009
|
27 |
Supplement 1 |
p. 6739-6747
9 p.
|
artikel
|
| 95 |
HLA haplotype and supertype associations with cellular immune responses and cytokine production in healthy children after rubella vaccine
|
Ovsyannikova, Inna G.
|
|
2009
|
27 |
Supplement 1 |
p. 3349-3358
10 p.
|
artikel
|
| 96 |
Homologous prime-boost strategy in neonate mice using Neisseria lactamica
|
Ito, André Y.
|
|
2009
|
27 |
Supplement 1 |
p. 3422-3428
7 p.
|
artikel
|
| 97 |
Hospital-based surveillance and molecular epidemiology of rotavirus infection in Taiwan, 2005–2007
|
Wu, F.T.
|
|
2009
|
27 |
Supplement 1 |
p. F50-F54
nvt p.
|
artikel
|
| 98 |
Household survey of hepatitis B vaccine coverage among Brazilian children
|
Luna, Expedito J.A.
|
|
2009
|
27 |
Supplement 1 |
p. 5326-5331
6 p.
|
artikel
|
| 99 |
How to compare the efficacy of conjugate vaccines to prevent acute otitis media?
|
De Wals, Philippe
|
|
2009
|
27 |
Supplement 1 |
p. 2877-2883
7 p.
|
artikel
|
| 100 |
Human dendritic cell maturation and activation by a heat-killed recombinant yeast (Saccharomyces cerevisiae) vector encoding carcinoembryonic antigen
|
Remondo, Cinzia
|
|
2009
|
27 |
Supplement 1 |
p. 987-994
8 p.
|
artikel
|
| 101 |
Human immunodeficiency virus-like particles with consensus envelopes elicited broader cell-mediated peripheral and mucosal immune responses than polyvalent and monovalent Env vaccines
|
McBurney, Sean P.
|
|
2009
|
27 |
Supplement 1 |
p. 4337-4349
13 p.
|
artikel
|
| 102 |
Human papillomavirus genotypes and phylogenetic analysis of HPV-16 variants in HIV-1 infected subjects in Italy
|
Tanzi, Elisabetta
|
|
2009
|
27 |
Supplement 1 |
p. A17-A23
nvt p.
|
artikel
|
| 103 |
Human papillomavirus (HPV) vaccine availability, recommendations, cost, and policies among health departments in seven Appalachian states
|
Katz, Mira L.
|
|
2009
|
27 |
Supplement 1 |
p. 3195-3200
6 p.
|
artikel
|
| 104 |
Human papillomavirus vaccine decision-making in Da Nang, Vietnam: Perceived spousal and adolescent–parent concordance
|
Breitkopf, Carmen Radecki
|
|
2009
|
27 |
Supplement 1 |
p. 2367-2371
5 p.
|
artikel
|
| 105 |
Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV
|
Jones, Bart
|
|
2009
|
27 |
Supplement 1 |
p. 1848-1857
10 p.
|
artikel
|
| 106 |
Humoral immunogenicity to measles, rubella, and varicella-zoster vaccines in biliary atresia children
|
Wu, Jia-Feng
|
|
2009
|
27 |
Supplement 1 |
p. 2812-2815
4 p.
|
artikel
|
| 107 |
Identification and characterization of novel immunogenic outer membrane proteins of Haemophilus parasuis serovar 5
|
Zhou, Mingguang
|
|
2009
|
27 |
Supplement 1 |
p. 5271-5277
7 p.
|
artikel
|
| 108 |
Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: A randomized, placebo-controlled trial
|
Kanungo, Suman
|
|
2009
|
27 |
Supplement 1 |
p. 6887-6893
7 p.
|
artikel
|
| 109 |
Immune responses in the airways by nasal vaccination with systemic boosting against Pseudomonas aeruginosa in chronic lung disease
|
Sorichter, Stephan
|
|
2009
|
27 |
Supplement 1 |
p. 2755-2759
5 p.
|
artikel
|
| 110 |
Immunisation with recombinant proteins subolesin and Bm86 for the control of Dermanyssus gallinae in poultry
|
Harrington, David
|
|
2009
|
27 |
Supplement 1 |
p. 4056-4063
8 p.
|
artikel
|
| 111 |
Immunity of cattle following vaccination with a Mannheimia haemolytica chimeric PlpE–LKT (SAC89) protein
|
Confer, A.W.
|
|
2009
|
27 |
Supplement 1 |
p. 1771-1776
6 p.
|
artikel
|
| 112 |
Immunization of young African green monkeys with OprF epitope 8–OprI–type A- and B-flagellin fusion proteins promotes the production of protective antibodies against nonmucoid Pseudomonas aeruginosa
|
Weimer, Eric T.
|
|
2009
|
27 |
Supplement 1 |
p. 6762-6769
8 p.
|
artikel
|
| 113 |
Immunization with HSV-1 glycoprotein C prevents immune evasion from complement and enhances the efficacy of an HSV-1 glycoprotein D subunit vaccine
|
Awasthi, Sita
|
|
2009
|
27 |
Supplement 1 |
p. 6845-6853
9 p.
|
artikel
|
| 114 |
Immunization with inflammatory proteome of Brugia malayi adult worm induces a Th1/Th2-immune response and confers protection against the filarial infection
|
Sahoo, M.K.
|
|
2009
|
27 |
Supplement 1 |
p. 4263-4271
9 p.
|
artikel
|
| 115 |
Immunogenicity and protective efficacy of ApxIA and ApxIIA DNA vaccine against Actinobacillus pleuropneumoniae lethal challenge in murine model
|
Chiang, Chung-Hao
|
|
2009
|
27 |
Supplement 1 |
p. 4565-4570
6 p.
|
artikel
|
| 116 |
Immunogenicity and safety of a tetanus toxoid, reduced diphtheria toxoid and three-component acellular pertussis vaccine in adults 19–64 years of age
|
Blatter, Mark
|
|
2009
|
27 |
Supplement 1 |
p. 765-772
8 p.
|
artikel
|
| 117 |
Immunogenicity and safety of intradermal versus intramuscular route of influenza immunization in infants less than 6 months of age: A randomized controlled trial
|
Chiu, Susan S.
|
|
2009
|
27 |
Supplement 1 |
p. 4834-4839
6 p.
|
artikel
|
| 118 |
Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months–2 years or 2–6 years primed with measles-mumps-rubella (MMR) vaccine
|
Gillet, Y.
|
|
2009
|
27 |
Supplement 1 |
p. 446-453
8 p.
|
artikel
|
| 119 |
Immunogenicity and tolerability of an HPV-16/18 AS04-adjuvanted prophylactic cervical cancer vaccine in women aged 15–55 years
|
Schwarz, Tino F.
|
|
2009
|
27 |
Supplement 1 |
p. 581-587
7 p.
|
artikel
|
| 120 |
Immunogenicity of a novel Stx2B–Stx1B fusion protein in a mice model of Enterohemorrhagic Escherichia coli O157:H7 infection
|
Gao, Xiang
|
|
2009
|
27 |
Supplement 1 |
p. 2070-2076
7 p.
|
artikel
|
| 121 |
Immunogenicity of 23-valent pneumococcal polysaccharide vaccine in HIV-infected pregnant women and kinetics of passively acquired antibodies in young infants
|
Almeida, Volia De Carvalho
|
|
2009
|
27 |
Supplement 1 |
p. 3856-3861
6 p.
|
artikel
|
| 122 |
Importance of subunit vaccine antigen of major Fli C antigenic site of Salmonella Enteritidis II: A challenge trial
|
Toyota-Hanatani, Yukiko
|
|
2009
|
27 |
Supplement 1 |
p. 1680-1684
5 p.
|
artikel
|
| 123 |
Improved immunization practices reduce childhood hepatitis B infection in Tonga
|
Danielsson, Niklas
|
|
2009
|
27 |
Supplement 1 |
p. 4462-4467
6 p.
|
artikel
|
| 124 |
Incidence of intussusception among children 0–5 years of age in Thailand, 2001–2006
|
Khumjui, Chowalit
|
|
2009
|
27 |
Supplement 1 |
p. F116-F119
nvt p.
|
artikel
|
| 125 |
Induction of HIV-1 subtype B and AE-specific neutralizing antibodies in mice and macaques with DNA prime and recombinant gp140 protein boost regimens
|
Center, Rob J.
|
|
2009
|
27 |
Supplement 1 |
p. 6605-6612
8 p.
|
artikel
|
| 126 |
Induction of humoral and enhanced cellular immune responses by novel core–shell nanosphere- and microsphere-based vaccine formulations following systemic and mucosal administration
|
Caputo, Antonella
|
|
2009
|
27 |
Supplement 1 |
p. 3605-3615
11 p.
|
artikel
|
| 127 |
Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy
|
Demento, Stacey L.
|
|
2009
|
27 |
Supplement 1 |
p. 3013-3021
9 p.
|
artikel
|
| 128 |
Influence of cytokine gene variations on immunization to childhood vaccines
|
Yucesoy, Berran
|
|
2009
|
27 |
Supplement 1 |
p. 6991-6997
7 p.
|
artikel
|
| 129 |
Influenza vaccination of health care workers in hospitals—A review of studies on attitudes and predictors
|
Hollmeyer, Helge G.
|
|
2009
|
27 |
Supplement 1 |
p. 3935-3944
10 p.
|
artikel
|
| 130 |
Influenza vaccination rates in Ontario children: Implications for universal childhood vaccination policy
|
Moran, Kathy
|
|
2009
|
27 |
Supplement 1 |
p. 2350-2355
6 p.
|
artikel
|
| 131 |
International Bordetella pertussis assay standardization and harmonization meeting report. Centers for Disease Control and Prevention, Atlanta, Georgia, United States, 19–20 July 2007
|
Tondella, M.L.
|
|
2009
|
27 |
Supplement 1 |
p. 803-814
12 p.
|
artikel
|
| 132 |
Internet-based monitoring of influenza-like illness in the general population: Experience of five influenza seasons in the Netherlands
|
Friesema, I.H.M.
|
|
2009
|
27 |
Supplement 1 |
p. 6353-6357
5 p.
|
artikel
|
| 133 |
Intradermal immunization improves protective efficacy of a novel TB vaccine candidate
|
Baldwin, Susan L.
|
|
2009
|
27 |
Supplement 1 |
p. 3063-3071
9 p.
|
artikel
|
| 134 |
Intranasal immunization with a mixture of PspA and a Toll-like receptor agonist induces specific antibodies and enhances bacterial clearance in the airways of mice
|
Oma, Keita
|
|
2009
|
27 |
Supplement 1 |
p. 3181-3188
8 p.
|
artikel
|
| 135 |
In vitro evidence that commercial influenza vaccines are not similar in their ability to activate human T cell responses
|
Co, Mary Dawn T.
|
|
2009
|
27 |
Supplement 1 |
p. 319-327
9 p.
|
artikel
|
| 136 |
In vivo anti-melanoma activities of the Melan-A/MART-1101–115 T CD4+ cell peptide
|
Balasse, Emilie
|
|
2009
|
27 |
Supplement 1 |
p. 6107-6109
3 p.
|
artikel
|
| 137 |
In vivo biodistribution of a highly attenuated recombinant vesicular stomatitis virus expressing HIV-1 Gag following intramuscular, intranasal, or intravenous inoculation
|
Erik Johnson, J.
|
|
2009
|
27 |
Supplement 1 |
p. 2930-2939
10 p.
|
artikel
|
| 138 |
Is the vaccination coverage established enough to control pertussis, or it is a re-emerging disease?
|
Cardeñosa, Neus
|
|
2009
|
27 |
Supplement 1 |
p. 3489-3491
3 p.
|
artikel
|
| 139 |
Liposomal Ag engrafted with peptides of sequence derived from HMGB1 induce potent Ag-specific and anti-tumour immunity
|
Faham, Abdus
|
|
2009
|
27 |
Supplement 1 |
p. 5846-5854
9 p.
|
artikel
|
| 140 |
Liposome-encapsulated HIV-1 Gag p24 containing lipid A induces effector CD4+ T-cells, memory CD8+ T-cells, and pro-inflammatory cytokines
|
Steers, Nicholas J.
|
|
2009
|
27 |
Supplement 1 |
p. 6939-6949
11 p.
|
artikel
|
| 141 |
Live vaccination with an H5-hemagglutinin-expressing infectious laryngotracheitis virus recombinant protects chickens against different highly pathogenic avian influenza viruses of the H5 subtype
|
Pavlova, Sophia P.
|
|
2009
|
27 |
Supplement 1 |
p. 5085-5090
6 p.
|
artikel
|
| 142 |
Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus
|
Zuccotti, Gian Vincenzo
|
|
2009
|
27 |
Supplement 1 |
p. 5357-5362
6 p.
|
artikel
|
| 143 |
Long-term efficacy of plasma-derived and recombinant hepatitis B vaccines in a rural township of Central Taiwan
|
Kao, Jung-Ta
|
|
2009
|
27 |
Supplement 1 |
p. 1858-1862
5 p.
|
artikel
|
| 144 |
Long-term persistence of tick-borne encephalitis antibodies in children 5 years after first booster vaccination with Encepur® Children
|
Wittermann, Christoph
|
|
2009
|
27 |
Supplement 1 |
p. 1585-1588
4 p.
|
artikel
|
| 145 |
Mechanism for increased immunogenicity of vaccines that form in vivo immune complexes with the natural anti-Gal antibody
|
Abdel-Motal, Ussama M.
|
|
2009
|
27 |
Supplement 1 |
p. 3072-3082
11 p.
|
artikel
|
| 146 |
Meningococcal carriage and disease—Population biology and evolution
|
Caugant, Dominique A.
|
|
2009
|
27 |
Supplement 1 |
p. B64-B70
nvt p.
|
artikel
|
| 147 |
MF59®-adjuvanted influenza vaccine (FLUAD®) in children: Safety and immunogenicity following a second year seasonal vaccination
|
Vesikari, T.
|
|
2009
|
27 |
Supplement 1 |
p. 6291-6295
5 p.
|
artikel
|
| 148 |
Modified live marker vaccine candidate CP7_E2alf provides early onset of protection against lethal challenge infection with classical swine fever virus after both intramuscular and oral immunization
|
Leifer, Immanuel
|
|
2009
|
27 |
Supplement 1 |
p. 6522-6529
8 p.
|
artikel
|
| 149 |
Molecular epidemiology of Japanese encephalitis in East Asia
|
Morita, Kouichi
|
|
2009
|
27 |
Supplement 1 |
p. 7131-7132
2 p.
|
artikel
|
| 150 |
Molecular insight into the immune up-regulatory properties of the leaf extract of Ashwagandha and identification of Th1 immunostimulatory chemical entity
|
Khan, Sheema
|
|
2009
|
27 |
Supplement 1 |
p. 6080-6087
8 p.
|
artikel
|
| 151 |
Monoclonal antibody based ELISA tests to detect antibodies against neuraminidase subtypes 1, 2 and 3 of avian influenza viruses in avian sera
|
Moreno, Ana
|
|
2009
|
27 |
Supplement 1 |
p. 4967-4974
8 p.
|
artikel
|
| 152 |
Multimeric soluble CD40 ligand (sCD40L) efficiently enhances HIV specific cellular immune responses during DNA prime and boost with attenuated poxvirus vectors MVA and NYVAC expressing HIV antigens
|
Gómez, Carmen E.
|
|
2009
|
27 |
Supplement 1 |
p. 3165-3174
10 p.
|
artikel
|
| 153 |
Neonatal pneumococcal conjugate vaccine immunization primes T cells for preferential Th2 cytokine expression: A randomized controlled trial in Papua New Guinea
|
van den Biggelaar, Anita. H.J.
|
|
2009
|
27 |
Supplement 1 |
p. 1340-1347
8 p.
|
artikel
|
| 154 |
Neutralizing activity and cellular immune responses induced in mice after immunization with apoptotic HIV-1/murine leukemia virus infected cells
|
Hinkula, Jorma
|
|
2009
|
27 |
Supplement 1 |
p. 6424-6431
8 p.
|
artikel
|
| 155 |
Novel Adenovirus type 5 vaccine platform induces cellular immunity against HIV-1 Gag, Pol, Nef despite the presence of Ad5 immunity
|
Gabitzsch, Elizabeth S.
|
|
2009
|
27 |
Supplement 1 |
p. 6394-6398
5 p.
|
artikel
|
| 156 |
Novel polysaccharide adjuvant from the roots of Actinidia eriantha with dual Th1 and Th2 potentiating activity
|
Sun, Hong-Xiang
|
|
2009
|
27 |
Supplement 1 |
p. 3984-3991
8 p.
|
artikel
|
| 157 |
Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis
|
Sun, Ronggai
|
|
2009
|
27 |
Supplement 1 |
p. 4412-4423
12 p.
|
artikel
|
| 158 |
Novel SIVmac DNA vaccines encoding Env, Pol and Gag consensus proteins elicit strong cellular immune responses in cynomolgus macaques
|
Yan, Jian
|
|
2009
|
27 |
Supplement 1 |
p. 3260-3266
7 p.
|
artikel
|
| 159 |
Packaging limits and stability of HIV-1 sequences in a coxsackievirus B vector
|
Miller, John P.
|
|
2009
|
27 |
Supplement 1 |
p. 3992-4000
9 p.
|
artikel
|
| 160 |
Peptide therapy for anti-CD4 autoimmunity in HIV-1 infection: Toward the development of an autoimmune animal model
|
Abulafia-Lapid, R.
|
|
2009
|
27 |
Supplement 1 |
p. 3475-3480
6 p.
|
artikel
|
| 161 |
Phase I therapeutic trial of the HIV-1 Tat protein and long term follow-up
|
Longo, Olimpia
|
|
2009
|
27 |
Supplement 1 |
p. 3306-3312
7 p.
|
artikel
|
| 162 |
Phenotypic and functional characteristics of HIV-specific CD8 T cells and gag sequence variability after autologous dendritic cells based therapeutic vaccine
|
López, Anna
|
|
2009
|
27 |
Supplement 1 |
p. 6166-6178
13 p.
|
artikel
|
| 163 |
Plasmodium falciparum apical membrane antigen 1 vaccine elicits multifunctional CD4 cytokine-producing and memory T cells
|
Huaman, Maria Cecilia
|
|
2009
|
27 |
Supplement 1 |
p. 5239-5246
8 p.
|
artikel
|
| 164 |
Plasmodium vivax recombinant vaccine candidate AMA-1 plays an important role in adaptive immune response eliciting differentiation of dendritic cells
|
Bueno, Lilian Lacerda
|
|
2009
|
27 |
Supplement 1 |
p. 5581-5588
8 p.
|
artikel
|
| 165 |
Population-based surveillance for severe rotavirus gastroenteritis in children in Karachi, Pakistan
|
Qazi, Romena
|
|
2009
|
27 |
Supplement 1 |
p. F25-F30
nvt p.
|
artikel
|
| 166 |
Positive role for rApxIVN in the immune protection of pigs against infection by Actinobacillus pleuropneumoniae
|
Wang, Chunlai
|
|
2009
|
27 |
Supplement 1 |
p. 5816-5821
6 p.
|
artikel
|
| 167 |
Possible autoimmune reactions following smallpox vaccination: The biologic false positive test for syphilis
|
Monath, Thomas P.
|
|
2009
|
27 |
Supplement 1 |
p. 1645-1650
6 p.
|
artikel
|
| 168 |
Potent anti-HPV immune responses induced by tandem repeats of the HPV16 L2 (20–38) peptide displayed on bacterial thioredoxin
|
Rubio, Ivonne
|
|
2009
|
27 |
Supplement 1 |
p. 1949-1956
8 p.
|
artikel
|
| 169 |
Preclinical evaluation of a modified vaccinia virus Ankara (MVA)-based vaccine against influenza A/H5N1 viruses
|
Kreijtz, J.H.C.M.
|
|
2009
|
27 |
Supplement 1 |
p. 6296-6299
4 p.
|
artikel
|
| 170 |
Predictive value of seizure ICD-9 codes for vaccine safety research
|
Shui, Irene M.
|
|
2009
|
27 |
Supplement 1 |
p. 5307-5312
6 p.
|
artikel
|
| 171 |
Preparation and characterization of an immunogenic meningococcal group A conjugate vaccine for use in Africa
|
Lee, Che-Hung
|
|
2009
|
27 |
Supplement 1 |
p. 726-732
7 p.
|
artikel
|
| 172 |
Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/Vietnam/1203/2004 influenza virus
|
Biesova, Zuzana
|
|
2009
|
27 |
Supplement 1 |
p. 6234-6238
5 p.
|
artikel
|
| 173 |
Prevalence and sequence variations of the genes encoding the five antigens included in the novel 5CVMB vaccine covering group B meningococcal disease
|
Jacobsson, Susanne
|
|
2009
|
27 |
Supplement 1 |
p. 1579-1584
6 p.
|
artikel
|
| 174 |
Prevalence of serum neutralizing antibodies against chimpanzee adenovirus 63 and human adenovirus 5 in Kenyan Children, in the context of vaccine vector efficacy
|
Dudareva, M.
|
|
2009
|
27 |
Supplement 1 |
p. 3501-3504
4 p.
|
artikel
|
| 175 |
Prevention of otitis media: Now a reality?
|
Schuerman, Lode
|
|
2009
|
27 |
Supplement 1 |
p. 5748-5754
7 p.
|
artikel
|
| 176 |
Prime–boost vaccination with a fowlpox vector and an inactivated avian influenza vaccine is highly immunogenic in Pekin ducks challenged with Asian H5N1 HPAI
|
Steensels, M.
|
|
2009
|
27 |
Supplement 1 |
p. 646-654
9 p.
|
artikel
|
| 177 |
Production of yellow fever virus in microcarrier-based Vero cell cultures
|
Souza, Marta Cristina O.
|
|
2009
|
27 |
Supplement 1 |
p. 6420-6423
4 p.
|
artikel
|
| 178 |
Protection against anthrax and plague by a combined vaccine in mice and rabbits
|
Ren, Jun
|
|
2009
|
27 |
Supplement 1 |
p. 7436-7441
6 p.
|
artikel
|
| 179 |
Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase
|
Pavlova, Sophia P.
|
|
2009
|
27 |
Supplement 1 |
p. 773-785
13 p.
|
artikel
|
| 180 |
Pseudoparticle neutralization is a reliable assay to measure immunity and cross-reactivity to H5N1 influenza viruses
|
Alberini, Isabella
|
|
2009
|
27 |
Supplement 1 |
p. 5998-6003
6 p.
|
artikel
|
| 181 |
Rabies DNA vaccine: No impact of MHC Class I and Class II targeting sequences on immune response and protection against lethal challenge
|
Kaur, Manpreet
|
|
2009
|
27 |
Supplement 1 |
p. 2128-2137
10 p.
|
artikel
|
| 182 |
Rabies virus pathogenesis in relationship to intervention with inactivated and attenuated rabies vaccines
|
Franka, Richard
|
|
2009
|
27 |
Supplement 1 |
p. 7149-7155
7 p.
|
artikel
|
| 183 |
Recombinant measles viruses expressing single or multiple antigens of human immunodeficiency virus (HIV-1) induce cellular and humoral immune responses
|
Liniger, Matthias
|
|
2009
|
27 |
Supplement 1 |
p. 3299-3305
7 p.
|
artikel
|
| 184 |
Recombinant Modified Vaccinia Ankara (MVA) effectively boosts DNA-primed HIV-specific immune responses in humans despite pre-existing vaccinia immunity
|
Gudmundsdotter, Lindvi
|
|
2009
|
27 |
Supplement 1 |
p. 4468-4474
7 p.
|
artikel
|
| 185 |
Reduced reaction frequencies with repeated inactivated or live-attenuated influenza vaccination
|
Ohmit, Suzanne E.
|
|
2009
|
27 |
Supplement 1 |
p. 1050-1054
5 p.
|
artikel
|
| 186 |
Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany
|
Rückinger, Simon
|
|
2009
|
27 |
Supplement 1 |
p. 4136-4141
6 p.
|
artikel
|
| 187 |
Relative importance of complement-mediated bactericidal and opsonic activity for protection against meningococcal disease
|
Granoff, Dan M.
|
|
2009
|
27 |
Supplement 1 |
p. B117-B125
nvt p.
|
artikel
|
| 188 |
Resistance to mycobacterial infection: A pattern of early immune responses leads to a better control of pulmonary infection in C57BL/6 compared with BALB/c mice
|
Arko-Mensah, John
|
|
2009
|
27 |
Supplement 1 |
p. 7418-7427
10 p.
|
artikel
|
| 189 |
Role of cell signaling in poxvirus-mediated foreign gene expression in mammalian cells
|
Hu, Ningjie
|
|
2009
|
27 |
Supplement 1 |
p. 2994-3006
13 p.
|
artikel
|
| 190 |
Role of lipid structure in the humoral immune response in mice to covalent lipid–peptides from the membrane proximal region of HIV-1 gp41
|
Watson, Douglas S.
|
|
2009
|
27 |
Supplement 1 |
p. 4672-4683
12 p.
|
artikel
|
| 191 |
Rotavirus hospitalization and molecular epidemiology in Northern Japan, 1987–1996
|
Nakagomi, Toyoko
|
|
2009
|
27 |
Supplement 1 |
p. F93-F96
nvt p.
|
artikel
|
| 192 |
Rotavirus infection in hospitalized children and estimates of disease burden in Kyrgyzstan, 2005–2007
|
Flem, Elmira T.
|
|
2009
|
27 |
Supplement 1 |
p. F35-F39
nvt p.
|
artikel
|
| 193 |
Rough mutants defective in core and O-polysaccharide synthesis and export induce antibodies reacting in an indirect ELISA with smooth lipopolysaccharide and are less effective than Rev 1 vaccine against Brucella melitensis infection of sheep
|
Barrio, María B.
|
|
2009
|
27 |
Supplement 1 |
p. 1741-1749
9 p.
|
artikel
|
| 194 |
Saccharomyces cerevisiae as a vaccine against coccidioidomycosis
|
Capilla, Javier
|
|
2009
|
27 |
Supplement 1 |
p. 3662-3668
7 p.
|
artikel
|
| 195 |
Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trial
|
Spearman, Paul
|
|
2009
|
27 |
Supplement 1 |
p. 243-249
7 p.
|
artikel
|
| 196 |
Safety and immunogenicity of a subvirion inactivated influenza A/H5N1 vaccine with or without aluminum hydroxide among healthy elderly adults
|
Brady, Rebecca C.
|
|
2009
|
27 |
Supplement 1 |
p. 5091-5095
5 p.
|
artikel
|
| 197 |
Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: Results of a Phase 2, randomized, double-blind placebo-controlled trial
|
Launay, Odile
|
|
2009
|
27 |
Supplement 1 |
p. 1184-1191
8 p.
|
artikel
|
| 198 |
Scheduling of measles vaccination in low-income countries: Projections of a dynamic model
|
Bauch, C.T.
|
|
2009
|
27 |
Supplement 1 |
p. 4090-4098
9 p.
|
artikel
|
| 199 |
Schistosoma mansoni ex vivo lung-stage larvae excretory–secretory antigens as vaccine candidates against schistosomiasis
|
Ridi, Rashika El
|
|
2009
|
27 |
Supplement 1 |
p. 666-673
8 p.
|
artikel
|
| 200 |
Serious adverse events rarely reported after trivalent inactivated influenza vaccine (TIV) in children 6–23 months of age
|
Rosenberg, Melissa
|
|
2009
|
27 |
Supplement 1 |
p. 4278-4283
6 p.
|
artikel
|
| 201 |
Serologic response to hepatitis B vaccine with high dose and increasing number of injections in HIV infected adult patients
|
Cruciani, Mario
|
|
2009
|
27 |
Supplement 1 |
p. 17-22
6 p.
|
artikel
|
| 202 |
Seroprevalence of anti-polio antibodies in a population 7 months to 39 years of age in Uruguay: Implications for future polio vaccination strategies
|
Pírez, María Catalina
|
|
2009
|
27 |
Supplement 1 |
p. 2689-2694
6 p.
|
artikel
|
| 203 |
Seroprevalence of bactericidal antibody against Neisseria meningitidis serogroup C in pre-vaccinal era: The Italian epidemiological scenario
|
Gasparini, R.
|
|
2009
|
27 |
Supplement 1 |
p. 3435-3438
4 p.
|
artikel
|
| 204 |
Sialivac: An intranasal homologous inactivated split virus vaccine containing bacterial sialidase for the control of avian influenza in poultry
|
Worrall, E.E.
|
|
2009
|
27 |
Supplement 1 |
p. 4161-4168
8 p.
|
artikel
|
| 205 |
Single- and multiple-clade influenza A H5N1 vaccines induce cross protection in ferrets
|
Forrest, Heather L.
|
|
2009
|
27 |
Supplement 1 |
p. 4187-4195
9 p.
|
artikel
|
| 206 |
Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults
|
Schwarz, Tino F.
|
|
2009
|
27 |
Supplement 1 |
p. 6284-6290
7 p.
|
artikel
|
| 207 |
SIP 1: Increasing the overall epidemic vaccination coverage Epidemic vaccination coverage:
|
|
|
2009
|
27 |
Supplement 1 |
p. 6370-6373
4 p.
|
artikel
|
| 208 |
sopB of Salmonella enterica serovar Typhimurium is a potential DNA vaccine candidate in conjugation with live attenuated bacteria
|
Nagarajan, Arvindhan G.
|
|
2009
|
27 |
Supplement 1 |
p. 2804-2811
8 p.
|
artikel
|
| 209 |
Status of natural infection with Japanese encephalitis virus in Japan: Prevalence of antibodies to the nonstructural 1 protein among humans and horses
|
Konishi, Eiji
|
|
2009
|
27 |
Supplement 1 |
p. 7129-7130
2 p.
|
artikel
|
| 210 |
Structural and immunogenicity studies of a cleaved, stabilized envelope trimer derived from subtype A HIV-1
|
Kang, Yun (Kenneth)
|
|
2009
|
27 |
Supplement 1 |
p. 5120-5132
13 p.
|
artikel
|
| 211 |
Surveillance of rotavirus in a rural diarrhoea treatment centre in Bangladesh, 2000–2006
|
Zaman, K.
|
|
2009
|
27 |
Supplement 1 |
p. F31-F34
nvt p.
|
artikel
|
| 212 |
Suspension-Vero cell cultures as a platform for viral vaccine production
|
Paillet, Cristian
|
|
2009
|
27 |
Supplement 1 |
p. 6464-6467
4 p.
|
artikel
|
| 213 |
T-cell vaccines that elicit effective immune responses against HCV in chimpanzees may create greater immune pressure for viral mutation
|
Zubkova, I.
|
|
2009
|
27 |
Supplement 1 |
p. 2594-2602
9 p.
|
artikel
|
| 214 |
The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine
|
Liu, Jun
|
|
2009
|
27 |
Supplement 1 |
p. 5077-5084
8 p.
|
artikel
|
| 215 |
The caveolin-1 binding domain of HIV-1 glycoprotein gp41 (CBD1) contains several overlapping neutralizing epitopes
|
Benferhat, Rima
|
|
2009
|
27 |
Supplement 1 |
p. 3620-3630
11 p.
|
artikel
|
| 216 |
The contribution of naturally occurring IgM antibodies, IgM cross-reactivity and complement dependency in murine humoral responses to pneumococcal capsular polysaccharides
|
Jones, Hannah E.
|
|
2009
|
27 |
Supplement 1 |
p. 5806-5815
10 p.
|
artikel
|
| 217 |
The effect of 23-valent pneumococcal polysaccharide vaccine on immunological priming induced by 7-valent conjugate vaccine in asplenic subjects with β-thalassemia
|
Orthopoulos, George V.
|
|
2009
|
27 |
Supplement 1 |
p. 350-354
5 p.
|
artikel
|
| 218 |
The first clinical use of a live-attenuated Listeria monocytogenes vaccine: A Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix
|
Maciag, Paulo Cesar
|
|
2009
|
27 |
Supplement 1 |
p. 3975-3983
9 p.
|
artikel
|
| 219 |
The mycobacterial glycolipid glucose monomycolate induces a memory T cell response comparable to a model protein antigen and no B cell response upon experimental vaccination of cattle
|
Nguyen, Thi Kim Anh
|
|
2009
|
27 |
Supplement 1 |
p. 4818-4825
8 p.
|
artikel
|
| 220 |
The novel adjuvant combination of CpG ODN, indolicidin and polyphosphazene induces potent antibody- and cell-mediated immune responses in mice
|
Kovacs-Nolan, J.
|
|
2009
|
27 |
Supplement 1 |
p. 2055-2064
10 p.
|
artikel
|
| 221 |
The novel adjuvant CoVaccineHT™ increases the immunogenicity of cell-culture derived influenza A/H5N1 vaccine and induces the maturation of murine and human dendritic cells in vitro
|
Bodewes, R.
|
|
2009
|
27 |
Supplement 1 |
p. 6833-6839
7 p.
|
artikel
|
| 222 |
Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C
|
Wedemeyer, Heiner
|
|
2009
|
27 |
Supplement 1 |
p. 5142-5151
10 p.
|
artikel
|
| 223 |
The strategy for prevention of measles and rubella prevalence with measles–rubella (MR) vaccine in Japan
|
Ihara, Toshiaki
|
|
2009
|
27 |
Supplement 1 |
p. 3234-3236
3 p.
|
artikel
|
| 224 |
The TLR3 agonist poly(I:C) targets CD8+ T cells and augments their antigen-specific responses upon their adoptive transfer into naïve recipient mice
|
Salem, Mohamed L.
|
|
2009
|
27 |
Supplement 1 |
p. 549-557
9 p.
|
artikel
|
| 225 |
TLR9 agonist, but not TLR7/8, functions as an adjuvant to diminish FI-RSV vaccine-enhanced disease, while either agonist used as therapy during primary RSV infection increases disease severity
|
Johnson, Teresa R.
|
|
2009
|
27 |
Supplement 1 |
p. 3045-3052
8 p.
|
artikel
|
| 226 |
Transcription of immune genes upon challenge with viral hemorrhagic septicemia virus (VHSV) in DNA vaccinated rainbow trout (Oncorhynchus mykiss)
|
Cuesta, A.
|
|
2009
|
27 |
Supplement 1 |
p. 280-289
10 p.
|
artikel
|
| 227 |
Universal childhood immunisation against Streptococcus pneumoniae: The five-year experience of Liguria Region, Italy
|
Durando, Paolo
|
|
2009
|
27 |
Supplement 1 |
p. 3459-3462
4 p.
|
artikel
|
| 228 |
Vaccination of children in low-resource countries against Shigella is unlikely to present an undue risk of reactive arthritis
|
Gaston, J. S. Hill
|
|
2009
|
27 |
Supplement 1 |
p. 5432-5434
3 p.
|
artikel
|
| 229 |
Vaccination with HPV16 L2E6E7 fusion protein in GPI-0100 adjuvant elicits protective humoral and cell-mediated immunity
|
Karanam, Balasubramanyam
|
|
2009
|
27 |
Supplement 1 |
p. 1040-1049
10 p.
|
artikel
|
| 230 |
Vaginal delivery of the recombinant HIV-1 clade-C trimeric gp140 envelope protein CN54gp140 within novel rheologically structured vehicles elicits specific immune responses
|
Curran, Rhonda M.
|
|
2009
|
27 |
Supplement 1 |
p. 6791-6798
8 p.
|
artikel
|
| 231 |
Viral load and clinical disease enhancement associated with a lentivirus cytotoxic T lymphocyte vaccine regimen
|
Mealey, Robert H.
|
|
2009
|
27 |
Supplement 1 |
p. 2453-2468
16 p.
|
artikel
|
| 232 |
Whole tumor cell vaccine with irradiated S180 cells as adjuvant
|
Li, Jinhua
|
|
2009
|
27 |
Supplement 1 |
p. 558-564
7 p.
|
artikel
|
Tijdschrift beschrijving